News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor
Monday, January 23, 2023Takeda announced that it has entered into an exclusive licensing agreement with HUTCHMED China Limited and its subsidiary HUTCHMED Limited for the further development
LG Chem Completes Acquisition of AVEO Oncology
Friday, January 20, 2023LG Chem Ltd announced that it has completed its previously announced acquisition of AVEO Oncology AVEO a commercial stage oncologyfocused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer...
Syner-G BioPharma Group Acquires RMC Pharmaceutical Solutions
Friday, January 20, 2023SynerG BioPharma Group SynerG a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients today announced the acquisition of RMC Pharmaceutical Solutions RMC Based in Boulder...
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
Thursday, January 19, 2023AC Immune SA a clinicalstage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases today announced that its collaboration partner Life Molecular Imaging LMI has imaged the first patient in ADvance the pivotal Phase t...
PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
Thursday, January 19, 2023PharmaTher Holdings Ltd a leader in specialty ketamine pharmaceuticals is pleased to announce that it has applied with the US Food and Drug Administration FDA to receive Orphan Drug Designation ODD for ketamine to treat Rett Syndrome a rare genetic n...
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
Wednesday, January 18, 2023TC Biopharm PLC a clinical stage biotechnology company developing platform allogeneic gammadelta T cell therapies for cancer treatment today announces a strategic collaboration with The University of Texas MD Anderson Cancer Center to expand the know...
Shineco Entered Into Framework Agreement Relating to Acquisition of Antiviral Fabric Producer Chongqing Wintus Group
Wednesday, January 18, 2023Shineco Inc a producer and distributor of Chinese herbal medicines organic agricultural products and other biotech products announced today that on January
PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
Friday, January 13, 2023PreveCeutical Medical Inc is pleased to announce that it has entered into a License Option Agreement with Endosane Pharmaceuticals GmbH Endosane a subsidiary of Sanity Group dated January pursuant to which Endosane has been granted an option to lic...
RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
Friday, January 13, 2023RespireRx Pharmaceuticals Inc a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling is pleased to announce that on January it established ResolutionRx Ltd...
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial
Wednesday, January 11, 2023Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems announced that it has successfully manufactured batches of its drug candidate MEAIbased...
